Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide TreatmentShu Ning, Allen C. Gao|Molecular Cancer Therapeutics|2022Cited by 21
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomesShu Ning, Allen C. Gao|Communications Medicine|2022Cited by 10